HELENA PUHALJ: Open Payments
NPI 1386756740 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 21 payments from 7 companies in 2025. Trend: 2023 $71 · 2024 $627 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $190 |
| Alkermes, Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Lundbeck LLC | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REXULTI, ARISTADA, COBENFY, CAPLYTA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, FANAPT, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
